Soluble branched (1,4)-β-D-glucans from Acetobacter species enhance antitumor activities against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response

International Journal of Cancer

Volumn 115, Issue 5, 2005, Pages 769-776

  Kamiryo, Yoriyuki ^a,b   Yajima, Toshiki ^a   Saito, Kimika ^a   Nishimura, Hitoshi ^a   Fushimi, Takashi ^c   Ohshima, Yoshifumi ^c   Tsukamoto, Yoshinori ^c   Naito, Seiji ^b   Yoshikai, Yasunobu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Mitsukan Group Corporation   (Japan)

Author keywords

(1,4) D glucans; Cytotoxic T lymphocyte; Major histocompatibility complex class I; Melanoma; Natural killer activity

Indexed keywords

AC 1; BETA 1,4 GLUCAN; BETA GLUCAN; CD8 ANTIGEN; GANGLIOSIDE ANTIBODY; INTERLEUKIN 12P40; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OKT 8; POLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACETOBACTER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; MACROPHAGE; MELANOMA; MELANOMA B16; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ACETOBACTER; ADMINISTRATION, ORAL; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENES, MHC CLASS I; GLUCANS; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MALE; MELANOMA; MICE; MICE, INBRED C57BL; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 20344373649     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20934     Document Type: Article

References (58)

1. Chihara G, Hamuro J, Maeda Y, Arai Y, Fukuoka F. Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Res 1970;30:2776-81.
2. Sugawara I, Lee KC, Wong M. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells: I, characteristics of SPG-treated macrophages. Cancer Immunol Immunother 1984;16:137-44.
3. Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K. Krestin (PSK). Cancer Treat Rev 1984;11:131-55.
4. Sabolovic D, Galoppin L. Effect of a protein bound polysaccharide (PS-K) on tumor development and infections in splenectomized rats and mice. Int J Immunopharmacol 1986;8:41-6.
5. Matsunaga K, Morita I, Oguchi Y, Fujii T, Yoshikumi C, Nomoto K. The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice. Anticancer Res 1987;7:509-12.
6. Suda M, Ohno N, Adachi Y, Yadomae T. Relationship between the tissue distribution and antitumor activity of highly branched (1→3)-beta-D-glucan, SSG. Biol Pharm Bull 1994;17:131-5.
7. Ebina T, Fujimiya Y. Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice. Biotherapy 1998;11:259-65.
8. Ohno N, Miura NN, Nakajima M, Yadomae T. Antitumor 1, 3-beta-glucan from cultured fruit body of Sparassis crispa. Biol Pharm Bull 2000;23:866-72.
9. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000;97:13766-71.
10. Bulut Y, Faure E, Thomas L, Equils O, Arditi M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 2001;167:987-94.
11. Ross P, Mayer R, Benziman M. Cellulose biosynthesis and function in bacteria. Microbiol Rev 1991;55:35-58.
12. Amor Y, Haigler CH, Johnson S, Wainscott M, Delmer DP. A membrane-associated form of sucrose synthase and its potential role in synthesis of cellulose and callose in plants. Proc Natl Acad Sci USA 1995:92:9353-7.
13. Thompson DN, Hamilton MA. Production of bacterial cellulose from alternate feedstocks. Appl Biochem Biotechnol 2001;91-3:503-13.
14. Cheng HP, Wang PM, Chen JW, Wu WT. Cultivation of Acetobacter xylinum for bacterial cellulose production in a modified airlift reactor. Biotechnol Appl Biochem 2002;35:125-32.
15. Peng L, Kawagoe Y, Hogan P, Delmer D. Sitosterol-β-glucoside as primer for cellulose synthesis in plants. Science 2002;295:147-50.
16. Nagata J, Higashiuesato Y, Maeda G, Chinen I, Saito M, Iwabuchi K, Onoe K. Effects of water-soluble hemicellulose from soybean hull on serum antibody levels and activation of macrophages in rats. J Agric Food Chem 2001;49:4965-70.
17. Saito K, Yajima T, Nishimura H, Aiba K, Ishimitsu R, Matsuguchi T, Fushimi T, Ohshima Y, Tsukamoto Y, Yoshikai Y. Soluble branched β-(1, 4)glucans from Acetobacter species show strong activities to induce interleukin-12 in vitro and inhibit T-helper 2 cellular response with immunoglobulin E production in vivo. J Biol Chem 2003;278:38571-8.
18. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170:827-45.
19. Markovic SN, Murasko DM. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma. Cancer Res 1991;51:1124-8.
20. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993;178:1223-30.
21. Yajima T, Nishimura H, Wajjwalku W, Harada M, Kuwano H, Yoshikai Y. Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response. Int J Cancer 2002;99:573-8.
22. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
23. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003;3:133-46.
24. - cells in metastatic processes. J Immunol 1986;136:4729-34.
25. + tumor-infiltrating lymphocytes. J Immunol 1994;153:1202-15.
26. Bellone M, Iezzi G, Manfredi AA, Protti MP, Dallabona P, Casorati G, Rugarli C. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells. Eur J Immunol 1994;24:2691-8.
27. Bloom MB, Perry-Lalley D, Robbins PF, Li Y, el-Gamil M, Rosenberg S, Yang JC. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J Exp Med 1997;185:453-9.
28. Harada M, Tamada K, Abe K, Li T, Onoe Y, Tada H, Tatsugami K, Ando T, Kimura G, Nomoto K. Characterization of B16 melanoma-specific cytotoxic T lymphocytes. Cancer Immunol Immunother 1998;47:198-204.
29. Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995;16:487-94.
30. Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359-93.
31. Lowin-Kropf B, Kunz B, Beermann F, Held W. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1. J Immunol 2000;165:1314-21.
32. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001;19:291-330.
33. Minakami H, Entani E, Tayama K, Fujiyama S, Masai H. Isolation and characterization of a new polysaccharide-producing Acetobacter sp. Agric Biol Chem 1984;48:2405-14.
34. Tayama K, Minakami H, Entani E, Fujiyama S, Masai H. Structure of an acidic polysaccharide from Acetobacter sp. NBI 1022. Agric Biol Chem 1985;49:959-66.
35. Tayama K, Minakami H, Fujiyama S, Masai H, Misaki A. Structure of an acidic polysaccharide elaborated by Acetobacter sp. NBI 1005. Agric Biol Chem 1986;50:1271-8.
36. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-12.
37. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001;291:2413-7.
38. + memory T cell subsets. Proc Natl Acad Sci USA 2004;101:5610-5.
39. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CDS T cells that give rise to long-lived memory cells. Nat Immunol 2003;4:1191-8.
40. Nanba H, Kuroda H. Antitumor mechanisms of orally administered shiitake fruit bodies. Chem Pharm Bull (Tokyo) 1987;35:2459-64.
41. + T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice. Int J Cancer 1997;70:362-72.
42. Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, Shike M, Weissfeld J, Burt R, Cooper MR, Kikendall JW, Cahill J. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 2000;342:1149-55.
43. Cheung NK, Modak S, Vickers A, Knuckles B. Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol Immunother 2002;51:557-64.
44. Cleary JA, Kelly GE, Husband AJ. The effect of molecular weight and β-1, 6-linkages on priming of macrophage function in mice by (1,3)-β-D-glucan. Immunol Cell Biol 1999;77:395-403.
45. Ikuzawa M, Matsunaga K, Nishiyama S, Nakajima S, Kobayashi Y, Ando T, Kobayashi A, Ohhara M, Ohmura Y, Wada T, Yoshikumi C. Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin). Int J Immunopharmacol 1988;10:415-23.
46. 125I-tyraminyl cellobiose. Immunopharmacology 1991;21:149-58.
47. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ, Lotze MT. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J Immunol 1994;153:1697-706.
48. Mu J, Zou JP, Yamamoto N, Tsutsui T, Tai XG, Kobayashi M, Herrmann S, Fujiwara H, Hamaoka T. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res 1995;55:4404-8.
49. Doherty PC, Allan JE. Anti-asialo GM1 eliminates both inflammatory process and cytotoxic T-cell function in the lymphocytic choriomeningitis adoptive transfer model. Cell Immunol 1987;107:1-7.
50. Whitmore MM, DeVeer MJ, Edling A, Oates RK, Simons B, Lindner D, Williams BR. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res 2004;64:5850-60.
51. Ballas ZK, Rasmussen WL, Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996;157:1840-5.
52. + T cells. J Immunol 2000;164:2009-15.
53. Tsukahara A, Seki S, Iiai T, Moroda T, Watanabe H, Suzuki S, Tada T, Hiraide H, Hatakeyama K, Abo T. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology 1997;26:301-9.
54. Keene JA, Forman J. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 1982;155:768-82.
55. Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Reinhardt RL, Itano A, Pape KA. In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 2001;19:23-45.
56. + T lymphocytes. Nature 2003;421:852-6.
57. Shedlock DG, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003;300:337-9.
58. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003;300:339-42.